SequelSEC

Xtant Medical Holdings, Inc. XTNT

Surgical & Medical Instruments & Apparatus · CIK 0001453593 · Fiscal year ends 1231

Revenue
$109.53M
Fiscal year ended 2026-06-30
Operating income
-$10.50M
Fiscal year ended 2026-06-30
Free cash flow
-$696.00K
Fiscal year ended 2026-06-30

Valuation, from the filing

Public float$45.00MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-06-30
Float per share$0.32Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / net income9.0×A lower bound on the multiple, because affiliate holdings are excluded.
Float / revenue0.3×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.9×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Surgical & Medical Instruments & Apparatus filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
R&D / revenue1.6%6th
Effective tax rate29.0%85th
SBC / revenue2.2%24th
FCF margin7.6%75th
Net margin3.7%74th
Operating margin5.4%72th
Long-term debt / equity0.22x30th
CapEx / revenue1.8%39th
Gross margin62.9%56th
Current ratio2.65x48th
Revenue YoY growth14.2%49th

Xtant Medical Holdings, Inc. (XTNT) reported revenue of $109.53M and net income of -$11.14M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from Xtant Medical Holdings, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Xtant Medical Holdings, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$109.53M
Cost of revenue$44.48M
Gross profit$65.05M
Operating income-$10.50M
Net income-$11.14M
Research & development$2.22M
Weighted-average diluted sharesUnavailable
Pretax income-$9.24M
Income tax expense$1.90M
Diluted EPSUnavailable
Selling, general & administrative$68.32M
General & administrative$27.07M
Selling & marketing$41.25M

Balance

Xtant Medical Holdings, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$9.87M
Total assets$79.67M
Current assets$64.78M
Total liabilities$39.65M
Current liabilities$29.96M
Total equity incl. NCI$40.02M
Temporary (mezzanine) equityUnavailable
Inventory$33.29M
Accounts receivable$19.42M
Goodwill$6.07M
Long-term debt$7.29M
Accounts payable$6.15M

Cash flow

Xtant Medical Holdings, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$570.00K
Capital expenditures$1.27M
Investing cash flow$14.39M
Financing cash flow-$12.03M
Net change in cash$3.18M
Stock-based compensation$2.95M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$4.02M

Derived

Xtant Medical Holdings, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow-$696.00K
Gross margin59.4%
Operating margin-9.6%
FCF margin-0.6%
SBC / revenue2.7%
Current ratio2.16x
Revenue YoY growth-14.3%
Net margin-10.2%
R&D / revenue2.0%
CapEx / revenue1.2%
Long-term debt / equity0.18x
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open XTNT in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-11View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-31View SEC filing
10-Q · Filed 2025-11-10View SEC filing
10-Q · Filed 2025-08-12View SEC filing
10-Q · Filed 2025-05-12View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.